3-Phenoxybenzoic acid (3-PBA) is a human urinary metabolite of many pyrethroid insecticides and can be used as a biomarker to monitor human exposure to these pesticides. A rapid and sensitive direct competitive fluorescence enzyme immunoassay (dc-FEIA) for detecting 3-PBA on the basis of a nanobody (Nb)−alkaline phosphatase (AP) fusion protein was developed. The anti-3-PBA Nb−AP fusion protein was expressed and purified. The 50% inhibitory concentration (IC 50 ) and linear range of dc-FEIA were 0.082 and 0.015−0.447 ng/mL, respectively, with a detection limit of 0.011 ng/mL. The IC 50 of dc-FEIA was improved by nearly ten times compared with those of one-step and three-step direct competitive enzyme-linked immunosorbent assay (dc-ELISA). Spiked urine samples were detected by both dc-FEIA and liquid chromatography−mass spectrometry (LC-MS), and the results showed good consistency between the two analysis methods, indicating the reliability of dc-FEIA based on the Nb−AP fusion protein for detecting 3-PBA in urine. Article pubs.acs.org/JAFC Cite This: J. Agric. Food Chem. XXXX, XXX, XXX−XXX
■ INTRODUCTION
Pyrethroids, one of the most widely used kinds of insecticides in the world, are mainly applied in agriculture, forestry, and horticulture for controlling insect pests. 1 Also, pyrethroids are used for controlling flies in indoor environments and can be used as medication for treating scabies and louse infestations. 2 Pyrethroids are among the safest insecticides marketed. However, because of the large-scale application and continuously increasing use of pyrethroids, a variety of people are exposed to pyrethroids at levels that could be harmful to humans and particularly to vulnerable subpopulations such as children. 3 For example, the potential effects include endocrine disruption, 4 DNA damage in human sperm, 5 primary ovarian insufficiency, 6 liver injury, 7 sensory alterations, 8 and others. 9, 10 Therefore, it is important to develop a rapid, sensitive, and efficient analytical method for environmental monitoring and assessment of human exposure to pyrethroids and to aid in proper use of these compounds. Most pyrethroids contain a phenoxybenzyl alcohol or cyanohydrin (Figure 1 ), and both of these esters can be hydrolyzed and converted to the corresponding acid. 3-Phenoxybenzoic acid (3-PBA) is a breakdown product of many pyrethroid insecticides and can be found in human urine. 11 The concentration of 3-PBA in urine provides information about a person's recent exposure to pyrethroid insecticides. Higher urine concentrations generally indicate more exposure; therefore, 3-PBA can be used as a biomarker to monitor human exposure to pyrethroid insecticides. 12, 13 At present, the detection methods for 3-PBA include supercritical-fluid chromatography, 14 gas chromatography, 15 high-performance liquid chromatography, 16 immunoassays, 17, 18 and optical sensing. 19 Among the above methods, immunoassays stand out because of their unique ability to routinely handle many samples. Also, tedious procedures and expensive equipment are not necessary in immunoassays. Monoclonal antibodies or polyclonal antibodies have often been used to detect 3-PBA in previously reported immunoassays, 11, 20 and secondary or tertiary antibodies were required in the process. In recent years, construction of antibody− alkaline phosphatase (AP) fusions based on recombinant DNA technology have shown a significant advantage in immunoassays. 21 For example, a recombinant fusion protein of singlechain variable fragment (scFv) and AP has been successfully applied in the detection of O,O-diethyl organophosphorus pesticides. 22 The single variable domains of heavy chain (VHH) antibodies, also called as nanobodies (Nb's), which have the properties of a small size and high solubility and stability, have become an attractive alternative to conventional scFv. The fusion of AP to Nb's has been applied in the detection of proteins 23 as well as small molecules, such as mycotoxins 24 and tetrabromobisphenol A. 25 Now, a few studies have reported on the application of Nb−AP fusions for the detection of pesticides or their metabolites. Recently, many fluorescent phosphatase substrates have been developed and commercialized. Most of those new fluorescent substrates are highly sensitive, maintaining a low fluorescence signal until enzymatically acted upon and even yielding detection of AP as low as 0.1 attomole. 26 On the basis of the highly sensitive substrate, the fluorescence assay can often exhibit more sensitive detection than the colorimetric assay. 27 Hence, Nb−AP fusions could be a powerful reagent for trace detection of pesticides or their metabolites.
In our previous work, seven VHH clones that showed good competitive binding with 3-PBA were selected from a phage VHH library that was constructed on the basis of an immunized alpaca. 28 In this study, the Nb−AP fusion was constructed using the above-mentioned VHH that showed the highest sensitivity. The fusion protein was expressed on the basis of the Nb gene and the expression vector pecan45 that contained the AP gene. 29 After the characterization and purification, the obtained fusion protein was used to develop a rapid and sensitive immunoassay method for detection of 3-PBA in urine.
■ MATERIALS AND METHODS
Chemicals and Reagents. T4 DNA ligase and restriction enzyme SfiI were purchased from New England Biolabs, Inc. (Beverly, MA). Phusion High-Fidelity DNA Polymerase, bacterial-protein-extraction reagent (B-PER), HisPur Ni-NTA resin, NuPAGE Bis-Tris Gel (precast polyacrylamide gels designed to give optimal separation for proteins of a wide molecular-weight range during gel electrophoresis), and Escherichia coli BL21 (DE3) pLysS were purchased from Thermo Fisher Scientific (Rockford, IL). Standards (3-phenoxybenzoic acid, 1, and its analogues, 3-phenoxybeneyl aldehyde and 3-phenoxybenzyl alcohol; permethrin, 2; cypermethrin, 3; deltamethrin, 4; fenpropathrin, 5; and phenothrin, 6; Figure 1 ), isopropyl-β-D-thiogalactopyranoside (IPTG), and p-nitrophenyl phosphate (pNPP) were purchased from Sigma (St. Louis, MO). 2′-(2-Benzothiazoyl)-6′hydroxybenzothiazole phosphate (BBTP) was purchased from Roche (Pleasanton, CA). AP-conjugated goat anti-mouse-IgG was purchased from Jackson ImmunoResearch Inc. (West Grove, PA). The vector pecan45 containing the AP gene was a generous gift from Dr. Jinny L. Liu and Dr. Ellen R. Goldman.
Construction of the Recombinant Plasmid and Expression and Purification of the Anti-3-PBA Nb−AP Fusion Protein. A recombinant plasmid encoding the Nb−AP fusion protein with a 6× His tag at its C-terminal end was constructed. Primers were used to amplify the Nb gene (forward primer: GAG GAG GAG GTG GCC CAG CCG GCC CAG GTG CAG CTC GTG GAG TCT GGG GGA, reverse primer: GAG GAG GAG CTG GCC CCC GAG GCC GCG TCT TGT GGT TTT GGT GTC TTG GG), and this was followed by a ligation reaction. The ligation products were then transformed into chemically competent cells of E. coli strain BL21(DE3) pLysS, which were then cultured on super broth (SB) agar plates containing 50 μg/mL ampicillin (Amp). All the super broth agar plates contained 50 μg/mL ampicillin in this study unless otherwise specified. Positive clones grown on the plates were picked for sequencing.
The target positive colony obtained from the above step was multiplied and induced by 0.1 mM IPTG at 25°C; this was followed by collection of the bacterial cells by centrifugation at 10 000g for 20 min. The crude fusion protein obtained by the B-PER method was purified by affinity chromatography using a high-capacity nickelimmobilized-metal-ion-resin column. The purification procedure was as follows: The wash buffer (10 mM PBS containing 25 mM imidazole, pH 7.4; the concentration and pH of PBS used in this study were 10 mM and 7.4, respectively, unless otherwise specified) was used to equilibrate the column; then, the Nb−AP fusion protein was eluted with elution buffer (PBS containing 100 mM imidazole). The collected elution buffer was dialyzed with PBS at 4°C for 72 h to obtain the Nb−AP fusion protein, which was then stored at −20°C for use. Sodium dodecyl sulfate−polyacrylamide-gel electrophoresis (SDS-PAGE) was used to evaluate the purity of the resulting Nb−AP fusion protein.
AP-Enzyme Activity of the Nb−AP Fusion Protein. 27 Colorimetric analysis is the most common method to measure AP enzyme activity. In order to compare the sensitivity of colorimetric analysis with fluorometric analysis, we measured the AP enzyme activity using the two analyses according to the reported method. 27 Briefly, the doubling dilution of the Nb−AP fusion protein and the substrates were added into 96-well microplates, which were incubated for 30 and 15 min at room temperature for colorimetric analysis and fluorometric analysis, respectively. The absorbance of the colorimetric analysis was measured at 405 nm after the reaction was stopped with 3 M NaOH. The fluorescence signals were measured at a 440 nm excitation wavelength and a 550 nm emission wavelength. Generally, the colorimetric analysis used the ordinary 96-well microplate, whereas the fluorometric analysis used the black, opaque 96-well microplate. The substrates for colorimetric analysis and fluorometric analysis were pNPP and BBTP, respectively.
One-Step Competitive Immunoassay for 3-PBA Based on the Obtained Fusion Protein. Colorimetric Enzyme Immunoassay. A 3-phenoxybenzoic acid−bovine serum albumin conjugate in PBS (400 ng/mL, 100 μL/well) was coated in the microplates overnight at 4°C and blocked with 200 μL per well 3% skim milk dissolved in PBS at room temperature for 1 h. Nb−AP (500 ng/mL, 50 μL/well) and equal volumes of different concentrations of the 3-PBA standard (0.01, 0.1, 0.2, 0.4, 1, 2, 4, 10, 20, 40, and 100 ng/mL), both diluted with PBS, were added to the microplate, which had been washed three times with PBS containing 0.5% Tween 20 (PBST). The microplates were shaken at 25°C for 1 h and then washed five times 
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Article with PBST. The enzyme activity was determined with the colorimetric assay, and the standard curve was obtained by plotting the value of B/ B 0 (%) against the 3-PBA concentration; B is the absorbance in the presence of 3-PBA, and B 0 is the absorbance in its absence.
For comparison, three-step competitive ELISA (colorimetric enzyme immunoassay) for the parental anti-3-PBA VHH fused with a C-terminal hemagglutinin (HA) tag was also studied. The coating and blocking procedures for the microplates were the same as above. The coating concentration for the three-step competitive ELISA was 50 ng/mL 1−BSA conjugate, and the concentration of VHH was 450 ng/mL. After the competitive reaction of 3-PBA and VHH, a 1:5000 dilution of anti-HA-tag mouse monoclonal antibody (100 μL) was added to the wells and incubated at 25°C for 30 min. After the washing procedure, in order to use the same substrate as was used with the one-step competitive immunoassay (colorimetric enzyme immunoassay), a 1:5000 dilution of AP-conjugated goat anti-mouse-IgG (100 μL/well) was added to the wells and incubated at 25°C for 30 min. Finally, AP substrate pNPP (150 μL/well) dissolved in the corresponding buffer was added, and the plate was incubated for 15 min. The reaction was stopped with 3 M NaOH, and the absorbance was determined at 405 nm on a microplate reader.
Fluorescence Enzyme Immunoassay. The coating and blocking procedures for this assay were the same as those used in the one-step colorimetric enzyme immunoassay. The difference was the microplate, which was a black, opaque 96-well microplate. In addition, the concentration of coating antigen for this assay was 25 ng/mL 1−BSA conjugate. After the blocking procedure, 50 μL of 20 ng/mL Nb−AP fusion protein and equal volumes of different concentrations of 3-PBA standards (0, 0.001, 0.005, 0.01, 0.025, 0.05, 0.1, 0.25, 0.5, and 1 ng/ mL) were added to each well, and the plate was incubated at 25°C for 1 h. BBTP (100 μL per well) dissolved in the corresponding buffer was added after the microplate was washed with PBST. The fluorescent signal was measured after the plate was incubated for 15 min at room temperature. The standard curve was obtained use the same formula as the colorimetric enzyme immunoassay, with B and B 0 changing to F and F 0 , respectively.
Analysis and Validation of Spiked Urine Sample Based on dc-FEIA and LC-MS. For the spiking and recovery study, urine samples, which were collected from healthy persons and proved by LC-MS to not contain 3-PBA, were fortified with 1, 2, and 4 ng/mL 3-PBA, respectively. The spiked urine samples were diluted with PBS to reach a final percentage of 5% urine/PBS (v/v), and then they were subjected to the one-step fluorescence enzyme immunoassay after complete mixing. LC-MS analysis was performed on Waters Acquity UPLC system coupled to a Xevo TQ-S Triple Quadrupole LC-MS. The above spiked urine samples (50 μL with 1, 2, and 4 ng/mL 3-PBA) were mixed with 50 μL of 200 nM 12-(3-cyclohexyl-ureido)dodecanoic acid in methanol, which was used as an internal standard to account for ion suppression, before detection. All data were obtained and processed using Masslynx 4.1 software with TargetLynx.
■ RESULTS AND DISCUSSION Expression, Purification, and Identification of the Nb−AP Fusion Protein. In order to express the fusion protein, the first thing we needed to do was construct the recombinant plasmid. After the amplification, ligation, and transformation procedures, the obtained positive recombinant plasmid was confirmed by colony PCR and DNA sequencing and then was transformed into chemically competent cells for expressing the soluble fusion protein. The crude fusion protein extracted by the B-PER reagent was purified by the Ni-NTA affinity columns, and SDS-PAGE was used to determine the size and integrity of the obtained Nb−AP fusion protein ( Figure 2 ). The result indicated an expected band of approximately 65 kDa for the Nb−AP fusion protein.
Enzyme Activity and Anti-3-PBA Reactivity of the Nb−AP Fusion Protein. In this study, the colorimetric and fluorometric analyses were used to evaluate the AP enzyme activity of the Nb−AP fusion protein. The results showed that the signal-to-noise had a positive correlation with the amount of Nb−AP fusion protein in both the fluorometric assay and colorimetric assay ( Figure 3 ). The limit of detection (signal-tonoise > 3) for AP enzyme activity in the fluorometric assay (dilution factor of 4000 times) was approximately 20 times lower than that in the colorimetric assay (dilution factor of 200 times), which indicated that the fluorometric assay had higher sensitivity than the colorimetric assay.
To evaluate the sensitivity of the Nb−AP fusion protein and compare its sensitivity with that of the parent VHH, one-step and three-step dc-ELISAs were carried out. The results showed that the binding between the antibody and coating antigen could be inhibited by the presence of 3-PBA in both of the assays, and the 50% inhibition concentrations were 0.811 and 0.740 ng/mL for one-step and three-step ELISAs, respectively, showing their similar sensitivities in 3-PBA detection ( Figure  4 ). This result indicated that the Nb−AP fusion protein in this study had similar binding properties to those of the parent VHH in the immunoassay, whereas the one-step immunoassay based on the Nb−AP fusion protein significantly reduced the assay time to 1 h when compared with the three-step ELISA, which required more than 3 h.
FEIA for 3-PBA Based on the Nb−AP Fusion Protein. The fact that the fluorometric assay was 20 times more sensitive than the colorimetric assay for the detection of AP enzyme activity ( Figure 3 ) indicated that higher sensitivity could be attained in FEIA compared with that in the conventional immunoassay. Therefore, dc-FEIA based on Nb−AP was developed, and the conditions for best performance of dc-FEIA were investigated in this study. The immunoreactions can be influenced by many assay parameters, 30, 31 such as the pH value, the ionic strength, the concentrations of coating antigen and antibody, and so on. Therefore, it is important to optimize these parameters to increase the sensitivity of 3-PBA detection. Generally, the best concentrations of coating antigen and antibody needed to be determined first. In this study, the best concentration combinations of 1−BSA conjugate (25 ng/mL) and Nb−AP fusion protein (20 ng/mL) were determined by checkerboard titration. Four different concentrations of PBS were tested to evaluate the effect of the ionic strength on assay performance. As can be seen from Figure 5A , the fluorescence intensity had a negative correlation with the ionic strength. Although the IC 50 values were not significantly different with different concentrations of PBS buffer, the lowest IC 50 of 0.076 ng/mL was obtained at 10 mM PBS. The effect of the pH value on dc-FEIA was determined in the range of pH 4.0−11.0 ( Figure  5B ). FEIA was most influenced at pH 6.0 and 11.0, with IC 50 values of 0.411 and 0.480 ng/mL, respectively. The maximum relative fluorescence unit (RFU max ) was observed abnormally at very low and high pHs, and the performance of Nb−AP did not exhibit the best activity. The best assay performance was obtained at pH 7.4, although pH values between 7.4 and 9.0 were equally suitable for the assay.
A standard curve was established using the optimal conditions obtained from the above study for dc-FEIA based on the Nb−AP fusion protein ( Figure 6 ). The standard curve had a good correlation coefficient of 0.994 and a limit of detection of 0.011 ng/mL. This assay had an IC 50 of 0.082 ng/ mL with a linear range of 0.015−0.447 ng/mL. The IC 50 of dc-FEIA was almost ten times lower than those of the one-step dc-ELISA (IC 50 = 0.811 ng/mL) and the three-step dc-ELISA (IC 50 = 0.740 ng/mL).
Cross-Reactivity. The specificity of the Nb−AP fusion protein based on the fluorometric enzyme immunoassay was studied using two 3-PBA analogues and five parent pyrethroids ( Table 1) . The cross-reactivity was calculated using the following formula: As shown in Table 1 , 3-phenoxybenzyl aldehyde had the highest cross reactivity of 22.6%. The result was consistent with the cross-reactivity pattern for the parent VHH, 28 indicating that Nb−AP fusion preserved the recognition features of the original VHH after fusion manipulation. Negligible cross reactivity with other 3-PBA analogues and parent pyrethroids demonstrated that the Nb−AP fusion protein had good selectivity and could effectively guarantee the detection of 3-PBA.
Matrix Effect. Matrix effects are common challenges for immunoassays because they can not only cause false positives and lower sensitivity, but they can also influence the assay specificity. 32 Many ways can be used to reduce the matrix effects. Sample-cleanup procedures such as solid-phase extraction are very useful for the removal of interferences. 33−35 Otherwise, dilution of the sample with assay buffer is another common method to reduce the matrix effects on immunoassays. 36 Because the main intended use of the developed FEIA method is for the evaluation of human and animal exposure to pyrethroids by detecting the common urinary metabolite 3-PBA, urine was selected for the matrix-effect evaluation. Urine samples were collected from healthy volunteers and proved to be negative for 3-PBA by LC-MS analysis (LOQ = 0.034 ng/ mL, LOD = 0.01 ng/mL). A serial concentration of 3-PBA standards was prepared using the undiluted urine, urine diluted 5-, 10-, 20-, 40-, and 50-fold in the assay buffer and assay buffer. The results (Figure 7) showed that the undiluted urine sample and the 5-fold-diluted urine sample showed low fluorescence and did not have IC 50 values, which indicated that the high concentration of urine had a significant influence on the performance of Nb−AP fusion. The maximum fluorescence intensity was not significantly reduced among the 10-, 20-, 40-, and 50-fold diluted urine samples and assay buffer, but the sensitivity was slightly affected in the 10-fold diluted urine sample. The above results indicated that the Nb− AP fusion protein was resistant to low concentrations of urine. The urine samples could be different between people, which should be considered; therefore, a 20-fold dilution was chosen as an optimal dilution for the developed assay. In general, dilution with assay buffer is a simple and effective method for reduction or elimination of the matrix effect in immunoassays, but the disadvantage of dilution is that it results in lower sensitivity. In our study, even with a 20-fold dilution factor, the final sensitivity of dc-FEIA for urine sample was maintained in the acceptable range because of the high sensitivity of the fluorometric-analysis format. Validation Study. In order to evaluate the reliability of dc-FEIA for detecting 3-PBA, the method was performed to analyze 3-PBA in the spiked urine samples, which were proved to be negative for 3-PBA by LC-MS before the spiking and recovery study. Three different concentrations of 3-PBA (1, 2, and 4 ng/mL) were spiked into urine samples, which were analyzed by dc-FEIA and LC-MS. The results showed that the average recoveries for dc-FEIA and LC-MS ranged from 84 to 109% and from 102 to 119%, respectively ( Table 2) , and the coefficients of variation for the two assays ranged from 0.046 to 0.136 (dc-FEIA) and from 0.076 to 0.154 (LC-MS). The above results indicated that the one-step dc-FEIA developed in this study had the properties of reliability, accuracy, and reproducibility, and it could be an important tool for detecting 3-PBA in urine samples.
In this work, a sensitive and reliable dc-FEIA based on a novel Nb−AP fusion protein for detecting 3-PBA in urine samples was successfully developed. The fluorometric detection exhibited remarkable advantages in terms of sensitivity compared with those of conventional colorimetric techniques. The IC 50 of dc-FEIA was nearly 10 times lower than that of the one-step and three-step dc-ELISAs. The high sensitivity of dc-FEIA compensated for the loss of sensitivity during the dilution of urine samples. In addition, the one-stepdetection format speeds up the assay procedure because no secondary or tertiary antibodies are required for one-step dc-FEIA. With these advantages, all the procedure for 3-PBA detection could be accomplished in 2 h from sample dilution to data analysis. These results indicate that the construction of Nb−AP fusions can be considered as an attractive and powerful reagent for immunoassay analysis, and the development of a fluorometric enzyme immunoassay can be a simple and rapid analytical tool for quantitative determinations of pesticides or their metabolites. 
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